Virtual Pharma-Payer Negotiations May Require More Persistence in COVID-19 Era
COVID-19 led to the cancellation of in-person meetings and conferences where pharmaceutical manufacturers connect with payers. Precision’s Andrew Cournoyer discusses our research results on the effects of the shift to virtual negotiations between pharma and payers, and the challenges they face going forward.